Medicinal Phytocompounds as Potential Inhibitors of p300-HIF1α Interaction: A Structure-Based Screening and Molecular Dynamics Simulation Study

Domain:

healthcare

Record type:

paper

Creator:

MuhAbrSohMoh

Host:

Background

Hypoxia plays a key role in cancer progression, mainly by stabilizing and activating hypoxia-inducible factor-1 (HIF-1). For HIF-1 to function under low oxygen conditions, it must interact with the transcriptional coactivator p300, a critical step for promoting cancer cell survival and adaptation in hypoxic environments.

Methods

Consequently, we used drug design and molecular simulation techniques to screen phytochemical databases, including traditional Chinese and African medicine sources, for compounds that could disrupt the p300/HIF-1 interaction.

Results

In this study, we identified potential compounds with high docking scores such as EA-176920 (−8.719), EA-46881231 (−8.642), SA-31161 (−9.580), SA-5280863 (−8.179), NE-5280362 (−10.287), NE-72276 (−9.017), NA-11210533 (−10.366), NA-11336960 (−7.818), TCM-5281792 (−12.648), and TCM-6441280 (−9.470 kcal/mol) as lead compounds. Furthermore, the compound with the highest docking score from each database (EA-176920, SA-31161, NE-5280362, NA-11210533, and TCM-5281792) was subjected to further analysis. The stable binding affinity of these compounds with p300 was confirmed by Post-simulation binding free energy (−22.0020 kcal/mol, −25.4499 kcal/mol, −32.4530 kcal/mol, −33.9918 kcal/mol, and −57.7755 kcal/mol, respectively) and KD analysis. Moreover, the selected compounds followed the Lipinski rules with favorable ADMET properties like efficient intestinal absorption, high water solubility, and no toxicity.

Conclusions

Our findings highlight the potential of natural compounds to target key protein–protein interactions in cancer and lay the groundwork for future in vitro and in vivo studies to explore their therapeutic potential. Specifically, disrupting the p300/HIF-1 interaction could interfere with hypoxia-driven pathways that promote tumor growth, angiogenesis, and metastasis, offering a promising strategy to suppress cancer progression at the molecular level.

Other Information

Published in: Pharmaceuticals
License: http://creativecommons.org/…
See article on publisher's website: https://doi.org/10.3390/ph1…

Visit

figshare.com

Licenses

CC BY 4.0

Prediction of Novel Insecticides for Malaria Prevention: Virtual Screening and Molecular Dynamics of AgAChE Inhibitors

Malaria is a prominent vector-borne disease, with a high mortality rate, particularly in children un

Neuroprotective potential of phenolic compounds from Cameroonian propolis: In vitro, molecular docking and molecular dynamics simulation studies

Propolis is a resinous plant-derived bee product with medicinal properties. In this study, three phe

Prospective virtual screening combined with bio-molecular simulation enabled identification of new inhibitors for the KRAS drug target

Abstract Lung cancer is a disease with a high mortality rate and it is the number one cause of cance

Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to inflict chaos gl

In silico screening and molecular dynamic simulation studies of potential small molecule immuno-modulators of the KIR2DS2 receptor

Cancer is reported to be one of the most common causes of global deaths and it accounted for an esti

Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease

Abstract 2020 has been highly affected by the COVID-19 outbreak. The urgent needs for a po